about
The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.Mixed-methods evaluation of a telehealth collaborative care program for persons with HIV infection in a rural settingAccuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis.Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes.Salmonella: a model for bacterial pathogenesis.The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole.Personal health record use and its association with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV.Medicare and Medicaid enrollment and outside hospitalizations among HIV-infected and uninfected veterans engaged in VA care: a retrospective cohort studyImpact of age on retention in care and viral suppressionQuality of HIV Care and Mortality Rates in HIV-Infected Patients.Searching for an optimal hand hygiene bundle: a meta-analysis.Racial Disparities in HIV Care Extend to Common Comorbidities: Implications for Implementation of Interventions to Reduce Disparities in HIV Care.Mixed-Methods Study of Uptake of the Extension for Community Health Outcomes (ECHO) Telemedicine Model for Rural Veterans With HIV.Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States.Geographic access and use of infectious diseases specialty and general primary care services by veterans with HIV infection: implications for telehealth and shared care programs.Comparative Effectiveness of Cefazolin versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.How Will New Guidelines Affect CD4 Testing in Veterans With HIV?HIV quality report cards: impact of case-mix adjustment and statistical methods.Trends in Hospitalization for Opioid Overdose among Rural Compared to Urban Residents of the United States, 2007-2014.Immortal Time Bias in Assessing Evidence-Based Care Processes for Staphylococcus aureus Bacteremia-Reply.Do brief screening questions or provider perception accurately identify persons with low health literacy in the HIV primary care setting?Patient and Facility Correlates of Racial Differences in Viral Control for Black and White Veterans with HIV Infection in the Veterans Administration."Availability of healthcare providers for rural veterans eligible for purchased care under the veterans choice act".Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteriaNovel Hospital Curtains with Antimicrobial Properties: A Randomized, Controlled TrialAdvancing telecare for pain treatment in primary care
P50
Q30268556-BDA7D029-1044-43FF-89AF-5D2C056BECA9Q30542924-CC3F3C86-214C-4DB8-ABEC-C3461957F22DQ30692742-D5161200-9D65-46AA-8AEE-CCCBF67025E4Q33629086-B34BCA1C-E51A-44D6-908D-C40900171464Q34131975-3119299E-B2F7-41E4-A98A-6081C69E024BQ34522155-13D1B443-3771-401F-98AD-2C5C813871ADQ34555082-F252A36B-D58D-40C9-B2CA-3D1BDB89B37FQ35018028-91C46343-3F8A-4A2A-85B4-A6C7B580BB68Q35102343-C0D7DBC0-6F2F-4692-AC2B-2A3572583129Q36402457-38B48830-6DF4-44EE-A60D-89B20587F4F3Q38150934-48B7675C-5DA4-44DD-9C5F-15026302FBB8Q39097835-8BF9F5A6-1D4D-408B-99B1-9CE9A924F138Q39457769-1E72223E-3898-45CA-B2FA-0375262D91DAQ40066467-E03341D0-C766-4904-B631-D6608317B90DQ40069947-A2E776D2-B197-4F91-A6ED-A021D5DC597CQ40182606-160D8A11-F511-46AE-8BC5-6CFA8D7EABEAQ40257163-AD869D6F-4308-43CB-A045-4D441B04BCA9Q40728578-C17499B8-3165-4DD2-914B-B6D604778045Q42205680-4ED846D6-8434-4152-A949-5167D758029AQ44350338-6BE5006B-7450-4D67-8538-816DB1409CD9Q50060800-777CED34-FB3A-4D86-87A5-79C5F5E932BAQ51751135-179A6FEB-BA51-4D73-8369-7A7BB89F77AFQ52604817-170C480E-F36F-4D4B-B044-9E66273D0FE8Q54956937-EA1A07D8-2239-4F76-995A-4113112DA5CFQ56934862-432DDC0C-AB08-483E-9E21-66501C5E481FQ56934869-4B777EA9-0540-4496-8CD9-D8D7065DD88AQ87400151-8FF739D8-F383-4E62-85EF-D7A220CDCEFF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael E Ohl
@ast
Michael E Ohl
@en
Michael E Ohl
@es
Michael E Ohl
@nl
type
label
Michael E Ohl
@ast
Michael E Ohl
@en
Michael E Ohl
@es
Michael E Ohl
@nl
prefLabel
Michael E Ohl
@ast
Michael E Ohl
@en
Michael E Ohl
@es
Michael E Ohl
@nl
P106
P1153
7003288645
P31
P496
0000-0001-7277-787X